C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response von VanDevanter, DR, Heltshe, SL, Skalland, M, West, NE, Sanders, DB, Goss, CH, Flume, PA

Volltext

Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation von Sanders, D.B., Khan, U., Heltshe, S.L., Skalland, M., West, N.E., VanDevanter, D.R., Goss, C.H., Flume, P.A.

Volltext

Building global development strategies for cf therapeutics during a transitional cftr modulator era von Mayer-Hamblett, N., van Koningsbruggen-Rietschel, S., Nichols, D.P., VanDevanter, D.R., Davies, J.C., Lee, T., Durmowicz, A.G., Ratjen, F., Konstan, M.W., Pearson, K., Bell, S.C., Clancy, J.P., Taylor-Cousar, J.L., De Boeck, K., Donaldson, S.H., Downey, D.G., Flume, P.A., Drevinek, P., Goss, C.H., Fajac, I., Magaret, A.S., Quon, B.S., Singleton, S.M., VanDalfsen, J.M., Retsch-Bogart, G.Z.

Volltext

Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment von VanDevanter, DR, Heltshe, SL, Sanders, DB, West, NE, Skalland, M, Flume, PA, Goss, CH

Volltext

Cystic fibrosis foundation position paper: Redefining the CF care model von Goetz, D.M., Brown, R.F., Filigno, S.S., Bichl, S.L., Nelson, A.L., Merlo, C.A., Juel, R., Lomas, P., Hempstead, S.E., Tran, Q., Brown, A.W., Flume, P.A.

Volltext

Antipseudomonal treatment decisions during CF exacerbation management von VanDevanter, D.R., West, N.E., Sanders, D.B., Skalland, M., Goss, C.H., Flume, P.A., Heltshe, S.L.

Volltext

Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis von VanDevanter, D.R, Flume, P.A, Morris, N, Konstan, M.W

Volltext

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis von VanDevanter, D.R, Heltshe, S.L, Spahr, J, Beckett, V.V, Daines, C.L, Dasenbrook, E.C, Gibson, R.L, Jain, R, Sanders, D.B, Goss, C.H, Flume, P.A

Volltext

Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study von Thompson, V, Mayer-Hamblett, N, Kloster, M, Bilton, D, Flume, P.A

Volltext

Infectious complications of lung transplantation : impact of cystic fibrosis von FLUME, P. A, EGAN, T. M, PARADOWSKI, L. J, DETTERBECK, F. C, THOMPSON, J. T, YANKASKAS, J. R

Volltext

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients von MANDURU, M, MIHM, L. B, WHITE, R. L, FRIEDRICH, L. V, FLUME, P. A, BOSSO, J. A

Volltext

Adults with cystic fibrosis in Portugal: A first step towards improvement von Raja, T.H, Flume, P.A

Volltext

Cystic Fibrosis: When To Consider Lung Transplantation? von Flume, Patrick A.

Volltext

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR von Wainwright, Claire E, Elborn, J. Stuart, Ramsey, Bonnie W, Marigowda, Gautham, Huang, Xiaohong, Cipolli, Marco, Colombo, Carla, Davies, Jane C, De Boeck, Kris, Flume, Patrick A, Konstan, Michael W, McColley, Susanna A, McCoy, Karen, McKone, Edward F, Munck, Anne, Ratjen, Felix, Rowe, Steven M, Waltz, David, Boyle, Michael P

Volltext

Prerenal azotemia from excessive sweating in an adult with a cystic fibrosis gene mutation von Tomov, S V, Flume, P A, Stenbit, A E, Ullian, M E

Volltext

Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: A Randomized Trial von Riker, Richard R, Shehabi, Yahya, Bokesch, Paula M, Ceraso, Daniel, Wisemandle, Wayne, Koura, Firas, Whitten, Patrick, Margolis, Benjamin D, Byrne, Daniel W, Ely, E. Wesley, Rocha, Marcelo G, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group, for the

Volltext

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection von TRAPNELL, Bruce C, MCCOLLEY, Susanna A, KISSNER, Dana G, ROLFE, Mark W, ROSEN, Jonathan M, MCKEVITT, Matthew, MOOREHEAD, Lisa, MONTGOMERY, A. Bruce, GELLER, David E

Volltext

Treatment of lung infection in patients with cystic fibrosis: Current and future strategies von Döring, Gerd, Flume, Patrick, Heijerman, Harry, Elborn, J. Stuart

Volltext

Linezolid Pharmacokinetics in Adult Patients with Cystic Fibrosis von BOSSO, John A, FLUME, Patrick A, GRAY, Susan L

Volltext

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an... von Flume, P. A., Biner, Fischer R., Downey, D. G.

Volltext